PNC Financial Services Group Inc. Invests $1.36 Million in Amrize Ltd $AMRZ

PNC Financial Services Group Inc. purchased a new stake in Amrize Ltd (NYSE:AMRZFree Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 28,022 shares of the company’s stock, valued at approximately $1,360,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. State of Wyoming acquired a new position in Amrize during the third quarter valued at approximately $32,000. Costello Asset Management INC acquired a new stake in Amrize in the third quarter worth $44,000. Global Retirement Partners LLC bought a new position in shares of Amrize during the third quarter worth $48,000. Jones Financial Companies Lllp acquired a new position in shares of Amrize in the 3rd quarter valued at $53,000. Finally, BNP Paribas Financial Markets acquired a new position in shares of Amrize in the 2nd quarter valued at $59,000.

Insider Activity at Amrize

In related news, CFO Ian A. Johnston acquired 1,200 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was bought at an average price of $63.92 per share, for a total transaction of $76,704.00. Following the acquisition, the chief financial officer directly owned 18,544 shares of the company’s stock, valued at approximately $1,185,332.48. The trade was a 6.92% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Amrize Price Performance

Shares of AMRZ opened at $63.59 on Tuesday. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.72. The stock has a market capitalization of $35.17 billion and a P/E ratio of 34.56. The company has a 50 day moving average of $56.23 and a 200-day moving average of $52.64.

Amrize (NYSE:AMRZGet Free Report) last announced its earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The business’s revenue for the quarter was down .4% compared to the same quarter last year.

Analyst Upgrades and Downgrades

AMRZ has been the topic of several research analyst reports. UBS Group raised their price objective on Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, January 8th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a report on Monday. Vertical Research assumed coverage on Amrize in a research note on Tuesday, November 25th. They set a “hold” rating and a $54.00 target price for the company. Berenberg Bank set a $70.00 price target on shares of Amrize in a research note on Thursday. Finally, Oppenheimer reiterated an “outperform” rating and issued a $70.00 price target (up previously from $64.00) on shares of Amrize in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Amrize currently has an average rating of “Moderate Buy” and a consensus target price of $63.43.

Check Out Our Latest Stock Analysis on AMRZ

About Amrize

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.